These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 1349031

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.
    Davey RT, Davey VJ, Metcalf JA, Zurlo JJ, Kovacs JA, Falloon J, Polis MA, Zunich KM, Masur H, Lane HC.
    J Infect Dis; 1991 Jul; 164(1):43-52. PubMed ID: 1676045
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression.
    Molina JM, Ferchal F, Chevret S, Barateau V, Poirot C, Morinet F, Modai J.
    AIDS; 1994 Jan; 8(1):27-33. PubMed ID: 7912084
    [Abstract] [Full Text] [Related]

  • 5. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
    Krown SE, Gold JW, Niedzwiecki D, Bundow D, Flomenberg N, Gansbacher B, Brew BJ.
    Ann Intern Med; 1990 Jun 01; 112(11):812-21. PubMed ID: 1971504
    [Abstract] [Full Text] [Related]

  • 6. Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection. HIV Protocol C91-253 Study Team.
    Krown SE, Aeppli D, Balfour HH.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar 01; 20(3):245-54. PubMed ID: 10077172
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: a phase I/II study.
    Wood R, Montoya JG, Kundu SK, Schwartz DH, Merigan TC.
    J Infect Dis; 1993 Mar 01; 167(3):519-25. PubMed ID: 8095058
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection.
    Frissen PH, van der Ende ME, ten Napel CH, Weigel HM, Schreij GS, Kauffmann RH, Koopmans PP, Hoepelman AI, de Boer JB, Weverling GJ.
    J Infect Dis; 1994 Jun 01; 169(6):1351-5. PubMed ID: 7910838
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068.
    Mildvan D, Bassiakos Y, Zucker ML, Hyslop N, Krown SE, Sacks HS, Zachary J, Paredes J, Fessel WJ, Rhame F, Kramer F, Fischl MA, Poiesz B, Wood K, Ruprecht RM, Kim J, Grossberg SE, Kasdan P, Bergé P, Marshak A, Pettinelli C.
    Antivir Ther; 1996 Apr 01; 1(2):77-88. PubMed ID: 11321183
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine.
    Berglund O, Engman K, Ehrnst A, Andersson J, Lidman K, Akerlund B, Sönnerborg A, Strannegård O.
    J Infect Dis; 1991 Apr 01; 163(4):710-5. PubMed ID: 1672701
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.